Efficacy and safety of Kuoxin Formula in the treatment of dilated cardiomyopathy-related heart failure (Qi-Yin deficiency combined with blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
Qiong Wu,
Shiying An,
Rueyjyh Lee
et al.
Abstract:Background Dilated cardiomyopathy (DCM) is a severe condition characterized by cardiac enlargement and declining heart function, often leading to refractory heart failure and life-threatening outcomes. Globally, and particularly in China, a notable challenge arises from the insufficient availability of targeted therapies demonstrating significant efficacy for DCM. Additionally, the application of traditional anti-heart failure drugs in DCM is constrained, as many patients exhibit a propensity for hypotension … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.